Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Nonparametric Estimation from Incomplete Observations
1958 • 7,673 citations
Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
1989 • 3,227 citations
The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.
1984 • 1,306 citations
Ventricular Premature Beats and Mortality after Myocardial Infarction
1977 • 659 citations
Risk factors for sudden death after acute myocardial infarction: Two-year follow-up
1984 • 548 citations
Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.
1979 • 466 citations
Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram
1984 • 279 citations
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS
1988 • 233 citations
Malignant ventricular tachyarrhythmias associated with the use of encainide
1981 • 215 citations
Effect of antiarrhythmic drugs on mortality after myocardial infarction
1983 • 202 citations
International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings
1984 • 186 citations
ORAL MEXILETINE IN HIGH-RISK PATIENTS AFTER MYOCARDIAL INFARCTION
1980 • 176 citations
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide
1986 • 153 citations
Risk factors for the development of proarrhythmic events
1987 • 131 citations
The cardiac arrhythmia pilot study
1986 • 130 citations
Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction
1980 • 105 citations
Effects of encainide and its metabolites on energy requirements for defibrillation.
1986 • 92 citations
A prospective randomized trial of tocainide in patients following myocardial infarction
1980 • 87 citations
Effect on survival after myocardial infarction of long-term treatment with phenytoin.
1978 • 77 citations
Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year.
1987 • 69 citations
Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available
1990 • 53 citations
Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction
1987 • 50 citations
Flecainide: Electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia
1985 • 50 citations
Drug‐Device Interactions: Clinical Considerations
1985 • 48 citations
Safety of encainide for the treatment of ventricular arrhythmias
1986 • 47 citations
Proarrhythmic responses during electrophysiologic testing
1987 • 38 citations
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)
1989 • 34 citations
Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction
1988 • 28 citations
Pharmacologic causes of arrhythmogenic actions of antiarrhythmic drugs
1987 • 24 citations
Cited By (0)
No citing papers found in database